Corrine Savill, Acting Chief Business Officer at Cullinan Oncology, Inc. (CGEM), sold 40,000 shares at $13.33 ($533K) on 2022-07-11, disclosed to the SEC on 2022-07-12.
Open-market sale of $533k CGEM by Acting Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.33 | 39,800 | $531K | 99.5% |
| 2 | $13.85 | 200 | $3K | 0.5% |
| Total | $13.33 avg | 40,000 | $533K | 100% |
| Filing → |
| CGEM | SELL | 2024-01-24 | $935K | — | Filing → |
| CGEM | SELL | 2022-07-21 | $607K | — | Filing → |